ScholarLens Back to search
2010•Annals of the Rheumatic DiseasesOpen access

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Marco Matucci‐Cerinic, CP Denton, D.E. Furst, Maureen D. Mayes, Vivien Hsu, Patrick Carpentier, Fredrick M Wigley, C. M. Black, Barri J. Fessler, Peter A. Merkel, Janet Pope, Nadera Sweiss, Mittie K. Doyle, Bernhard Hellmich, Thomas A. Medsger, A. Morganti, Fabrice Kramer, J H Korn, James R. Seibold

Open full text 503 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 503 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Bosentan, Placebo, Double blind, Scleroderma (fungus), Internal medicine, Randomized controlled trial, Dermatology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial — Research Paper | ScholarLens